BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26272263)

  • 1. Polymorphism in apoptotic BAX (-248G>A) gene but not in anti-apoptotic BCL2 (-938C>A) gene and its protein and mRNA expression are associated with cervical intraepithelial neoplasia.
    Fernandes AT; Rocha NP; Vendrame E; Russomano F; Grinsztejn BJ; Friedman RK; Pinto AC; Klumb EM; Avvad E; Macedo J; Martínez-Maza O; Bonecini-Almeida Mda G
    Apoptosis; 2015 Oct; 20(10):1347-57. PubMed ID: 26272263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of BCL2-938C>A and BAX-248G>A promoter polymorphisms in the development of AML: case-control study from South India.
    Cingeetham A; Vuree S; Dunna NR; Gorre M; Nanchari SR; Edathara PM; Meka P; Annamaneni S; Digumarthi R; Sinha S; Satti V
    Tumour Biol; 2015 Sep; 36(10):7967-76. PubMed ID: 25957891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Balance of apoptotic and anti-apoptotic marker and perforin granule release in squamous intraepithelial lesions. HIV infection leads to a decrease in perforin degranulation.
    Fernandes AT; da Rocha NP; Avvad E; Grinsztejn BJ; Russomano F; Tristão A; Quintana Mde S; Perez MA; Conceição-Silva F; Bonecini-Almeida Mda G
    Exp Mol Pathol; 2013 Oct; 95(2):166-73. PubMed ID: 23791892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Evaluation of the Impact of Polymorphic Variants in Apoptotic (
    Moawadh MS; Mir R; Tayeb FJ; Asim O; Ullah MF
    Curr Issues Mol Biol; 2023 May; 45(5):3933-3952. PubMed ID: 37232720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of
    Al-Zubaidy HFS; Majeed SR; Al-Koofee DAF
    Arch Razi Inst; 2022 Apr; 77(2):799-808. PubMed ID: 36284943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of Bcl-2 and Bax proteins in cervical carcinogenesis: an immunohistochemical study in squamous cell carcinoma and squamous intraepithelial lesions.
    Cheah PL; Looi LM
    Malays J Pathol; 2006 Jun; 28(1):1-5. PubMed ID: 17694953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.
    Peng Y; Wang L; Qing Y; Li C; Ren T; Li Q; Li M; Zhang S; Shan J; Wang G; Yang Z; Wang D
    Sci Rep; 2015 Dec; 5():17766. PubMed ID: 26656462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic and epigenetic analysis of the BAX and BCL2 in the placenta of pregnant women complicated by preeclampsia.
    Mohammadpour-Gharehbagh A; Jahantigh D; Eskandari M; Sadegh MH; Nematollahi MH; Rezaei M; Rasouli A; Eskandari F; Heydarabad MZ; Teimoori B; Salimi S
    Apoptosis; 2019 Apr; 24(3-4):301-311. PubMed ID: 30701356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of the Polymorphisms and Expression Levels of the BCL2, BAX and c-MYC Genes in Patients with Ovarian Cancer.
    Olbromski PJ; Bogacz A; Bukowska M; Kamiński A; Moszyński R; Pawlik P; Szeliga A; Kotrych K; Czerny B
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis.
    Lai HC; Sytwu HK; Sun CA; Yu MH; Yu CP; Liu HS; Chang CC; Chu TY
    Int J Cancer; 2003 Jan; 103(2):221-5. PubMed ID: 12455036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAX and BCL-2 polymorphisms, as predictors of proliferative vitreoretinopathy development in patients suffering retinal detachment: the Retina 4 project.
    Pastor-Idoate S; Rodríguez-Hernández I; Rojas J; Fernández I; García-Gutierrez MT; Ruiz-Moreno JM; Rocha-Sousa A; Ramkissoon YD; Harsum S; MacLaren RE; Charteris DG; Van Meurs JC; González-Sarmiento R; Pastor JC;
    Acta Ophthalmol; 2015 Nov; 93(7):e541-9. PubMed ID: 25991504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Codon 72 polymorphism of p53 as a risk factor for patients with human papillomavirus-associated squamous intraepithelial lesions and invasive cancer of the uterine cervix.
    Yamashita T; Yaginuma Y; Saitoh Y; Kawai K; Kurakane T; Hayashi H; Ishikawa M
    Carcinogenesis; 1999 Sep; 20(9):1733-6. PubMed ID: 10469618
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Single-nucleotide polymorphisms at the TP53-binding or responsive promoter regions of BAX and BCL2 genes and risk of squamous cell carcinoma of the head and neck.
    Chen K; Hu Z; Wang LE; Sturgis EM; El-Naggar AK; Zhang W; Wei Q
    Carcinogenesis; 2007 Sep; 28(9):2008-12. PubMed ID: 17693666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas gene promoter -670 polymorphism (A/G) is associated with cervical carcinogenesis.
    Ueda M; Hung YC; Terai Y; Yamaguchi H; Saito J; Nunobiki O; Noda S; Ueki M
    Gynecol Oncol; 2005 Jul; 98(1):129-33. PubMed ID: 15894356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BAX and BCL2 Gene Polymorphisms in Rhegmatogenous Retinal Detachment.
    Moschos MM; Chatziralli I; Brouzas D; Gazouli M
    Ophthalmic Res; 2017; 58(4):227-230. PubMed ID: 28877516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional inactivation of p53, Bax, Bcl-2 and Mdm2 correlates with malignant transformation of the uterine cervix.
    Soufla G; Baritaki S; Sifakis S; Zafiropoulos A; Spandidos DA
    Int J Biol Markers; 2005; 20(1):18-27. PubMed ID: 15832769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma.
    Lehnerdt GF; Franz P; Bankfalvi A; Grehl S; Kelava A; Nückel H; Lang S; Schmid KW; Siffert W; Bachmann HS
    Ann Oncol; 2009 Jun; 20(6):1094-9. PubMed ID: 19196738
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of bcl-2 and bax in cervical intraepithelial neoplasia and invasive squamous cell carcinoma of the uterine cervix.
    Aletra C; Ravazoula P; Scopa C; Kounelis S; Sotiropoulou G; Kourounis G; Ladopoulos I; Bonikos D
    Eur J Gynaecol Oncol; 2000; 21(5):494-8. PubMed ID: 11198041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDM2 SNP 309 human papillomavirus infection in cervical carcinogenesis.
    Nunobiki O; Ueda M; Yamamoto M; Toji E; Sato N; Izuma S; Okamoto Y; Torii K; Noda S
    Gynecol Oncol; 2010 Sep; 118(3):258-61. PubMed ID: 20538323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and clinical significance of Dyrk1b in the specimens and cells of cervical lesions].
    Lin J; Zhang P; Pang L; Chen J; Sun W; Qi W; Lyu Y; Guan H; Gao J
    Zhonghua Fu Chan Ke Za Zhi; 2016 Jan; 51(1):40-5. PubMed ID: 26899006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.